Skip to Main Content

Paper Details

BRAF Mutations-A Good News Story for Immune Checkpoint Inhibitors in Oncogene-Addicted NSCLC?
J Thorac Oncol
2
2018
Author NameAffiliation
Paul MitchellOlivia-Newton John Cancer Research Institute, University of Melbourne
  • 1 - 1

Datasets

Release 1.2